Related Experiment Video

Updated: Aug 29, 2026

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification
10:21

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification

Published on: September 20, 2024

Tumor necrosis factor-alpha antagonists induce lupus-like syndrome in patients with scleroderma overlap/mixed

Lisa Christopher-Stine, Fredrick Wigley

    The Journal of Rheumatology
    |January 14, 2004
    PubMed
    Abstract

    No abstract available in PubMed .

    Related Experiment Videos

    Last Updated: Aug 29, 2026

    Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification
    10:21

    Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification

    Published on: September 20, 2024

    Related Concept Videos

    Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

    Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

    Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
    T Cell Types and Functions01:24

    T Cell Types and Functions

    When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
    Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

    Articles linked to this work by shared authors, journal, and citation graph.

    Proteomic Signatures and an Injury-Stress Endotype in Myositis-Associated Interstitial Lung Disease.

    medRxiv : the preprint server for health sciences·2026

    A wearable biomechanical system for medical evaluation of soft tissue disorders.

    Science advances·2026

    Fibrosing myopathy in systemic sclerosis: Treatment response and clinical outcomes in a distinct subset.

    Seminars in arthritis and rheumatism·2026

    From Serendipity to Science: How Anti-HMGCR Antibodies Changed Our Understanding of Myositis.

    The Journal of rheumatology·2026

    Quantitative Muscle Magnetic Resonance Imaging Demonstrates Resolution of Muscle Edema in Refractory Dermatomyositis: A Post Hoc Analysis of a Proof-of-Concept Clinical Trial of Tofacitinib.

    ACR open rheumatology·2026

    A Phase 3 Trial of Brepocitinib in Dermatomyositis.

    The New England journal of medicine·2026

    Clinical features and a Nomogram for predicting clinical response in juvenile dermatomyositis associated interstitial lung disease.

    The Journal of rheumatology·2026

    Validation of Handheld Ultrasound Devices for Point of Care Use in Rheumatology Study- Focus on Synovitis, Doppler Activity, Erosions, and Tendon Lesions.

    The Journal of rheumatology·2026

    What Defines an MRI Considered Indicative of Axial Spondyloarthritis in the Sacroiliac Joints: A Systematic Literature Review.

    The Journal of rheumatology·2026

    Disorders of Gut-Brain Interaction in Juvenile Fibromyalgia Syndrome: Prevalence, Clinical Characteristics, and Management in a Single-Centre Cohort Study.

    The Journal of rheumatology·2026

    Patient-Reported Outcomes Following Discontinuation Of Tumor Necrosis Factor Inhibitors In Rheumatoid Arthritis Remission/Low Disease Activity: A Randomized Placebo-Controlled Trial.

    The Journal of rheumatology·2026

    Transition From Systemic Sclerosis to Interstitial Lung Disease: Methodological Considerations.

    The Journal of rheumatology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us